StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
84
Publishing Date
2024 - 03 - 28
97
2024 - 01 - 16
102
2024 - 01 - 08
125
2023 - 11 - 27
98
2023 - 11 - 09
96
2023 - 11 - 08
105
2023 - 11 - 07
109
2023 - 11 - 06
116
2023 - 11 - 02
125
2023 - 11 - 01
122
2023 - 10 - 31
94
2023 - 10 - 26
121
2023 - 10 - 24
107
2023 - 10 - 23
104
2023 - 10 - 19
96
2023 - 10 - 10
94
2023 - 10 - 02
94
2023 - 09 - 27
96
2023 - 09 - 26
107
2023 - 09 - 07
114
2023 - 08 - 10
98
2023 - 08 - 09
96
2023 - 08 - 03
105
2023 - 07 - 27
106
2023 - 07 - 25
116
2023 - 06 - 27
114
2023 - 06 - 20
114
2023 - 05 - 16
106
2023 - 05 - 11
120
2023 - 05 - 09
106
2023 - 05 - 04
106
2023 - 05 - 03
98
2023 - 05 - 02
114
2023 - 04 - 27
94
2023 - 04 - 24
102
2023 - 04 - 19
102
2023 - 04 - 18
94
2023 - 04 - 17
108
2023 - 03 - 14
114
2023 - 02 - 22
106
2023 - 02 - 21
98
2023 - 02 - 09
98
2022 - 10 - 25
100
2022 - 06 - 29
96
2022 - 04 - 28
94
2022 - 04 - 26
95
2022 - 03 - 08
102
2022 - 03 - 01
99
2022 - 02 - 24
98
2022 - 02 - 23
97
2022 - 02 - 22
95
2021 - 11 - 03
100
2021 - 10 - 21
119
2021 - 10 - 20
98
2021 - 10 - 14
108
2021 - 10 - 13
96
2021 - 10 - 07
95
2021 - 09 - 09
95
2021 - 09 - 08
94
2021 - 05 - 05
96
Sector
Commercial services
1
Communications
2
Consumer durables
3
Consumer non-durables
1
Consumer services
3
Electronic technology
4
Energy minerals
2
Finance
5
Health services
3
Health technology
35
Information
1
Manufacturing
11
Mining, quarrying, and oil and gas extraction
1
Non-energy minerals
2
Process industries
2
Producer manufacturing
5
Retail trade
1
Technology services
1
Utilities
1
Tags
Alliances
3
Als
9
Application
2
Approval
4
Biopharma
2
Biotech-beach
2
Cancer
6
Children
2
Clearance
2
Clinical-trials-phase-ii
6
Collaboration
2
Conference
2
Contract
5
Covid
3
Covid-19
3
Designation
2
Diabetes
2
Drug
4
Ema
9
Europe
4
Events
2
Fda
4
Fda clearance
2
Genetown
2
Grant
2
Granted
3
Health
3
Iot
3
Last mile
2
Liver
4
Lung cancer
3
Media
2
Merge
2
N/a
52
New drug
2
Partnership
4
Patent
2
Pharm-country
4
Phase 1
6
Phase 1b
2
Phase 2
4
Phase 2b
3
Phase 3
3
Platform
4
Positive
9
Potential
2
Pre-clinical
2
Preclinical
2
Presentation
3
Research
10
Results
7
Syndros
2
T-cell
5
Technology
3
Test
3
Therapeutics
15
Therapy
6
Topline
2
Treatment
12
Trial
13
Entities
4d pharma plc - adr
1
Abbvie inc.
1
Adagene inc - adr
1
Air products and chemicals, inc.
1
Alianza minerals ltd.
1
Alnylam pharmaceuticals, inc.
1
Ansys, inc.
1
Apollo global management, inc
1
Aprea therapeutics, inc.
1
Aquestive therapeutics, inc.
1
Arch therapeutics, inc.
1
Aries i acquisition corp - class a
1
Atai life sciences n.v.
1
Aytu bioscience, inc.
1
Bellus health inc.
1
Biohaven pharmaceutical holding company ltd.
1
Brainstorm cell therapeutics inc.
1
Canadian solar inc.
1
Canagold resources ltd.
1
Candelaria mining corp.
1
Capricor therapeutics, inc.
1
Centene corporation
1
Clear channel outdoor holdings, inc.
1
Cnh industrial n.v.
1
Coherus biosciences, inc.
1
Cullinan management inc
1
Cumulus media inc.
2
Cypress development corp
1
Electrocore, inc.
1
Eli lilly and company
2
Empower clinics inc.
2
Fate therapeutics, inc.
2
Flex lng ltd.
1
Foghorn therapeutics inc.
1
Ford motor company
1
Fortress biotech, inc.
1
Galectin therapeutics inc.
1
Galecto, inc.
1
Genmab a/s
1
Global industrial co
1
Group ten metals inc
1
Harpoon therapeutics, inc.
1
Inotiv inc
1
Intellia therapeutics, inc.
1
Jaguar health, inc.
1
Jazz pharmaceuticals plc
1
Johnson & johnson
1
Keros therapeutics, inc.
1
Knowbe4 inc - class a
1
Kymera therapeutics, inc.
1
Lightpath technologies, inc.
1
Medicinova, inc.
1
Mgm resorts international
1
Millicom international cellular s.a.
1
Mmex resources corp
1
Morgan stanley
2
Mustang bio, inc.
1
Navidea biopharmaceuticals, inc.
1
Nektar therapeutics
1
Xos inc
2
Symbols
ABBV
1
ADAG
1
ALNY
1
ANSS
1
APD
1
APO
1
APRE
1
AQST
1
ARTH
1
ATAI
1
AYTU
1
BCLI
1
BHVN
1
BLU
1
CAPR
1
CCO
1
CDELF
1
CGEM
1
CHRS
1
CMLS
2
CNC
1
CNHI
1
CRCUF
1
CSIQ
1
CYDVF
1
ECOR
1
EPWCF
2
F
1
FATE
2
FBIO
1
FHTX
1
FLNG
1
FLOW
1
FNCTF
1
GALT
1
GIC
1
GLTO
1
GMAB
1
GNMSF
1
HARP
1
JAGX
1
JAZZ
1
JNJ
1
KNBE
1
KROS
1
KYMR
1
LBPS
1
LLY
2
LPTH
1
MBIO
1
MGM
1
MMEX
1
MNOV
1
MS
2
NAVB
1
NGD
1
NKTR
1
NOTV
1
NTLA
1
XOS
2
Exchanges
Amex
2
Nasdaq
63
Nyse
24
Crawled Date
2021 - 12 - 14
1
2021 - 12 - 13
83
Crawled Time
00:00
1
01:00
1
08:00
3
09:00
1
11:00
1
12:00
4
12:30
5
13:00
4
13:30
6
14:00
10
14:30
6
15:00
4
15:30
5
16:00
2
17:00
2
18:00
1
19:00
3
20:00
1
21:00
16
22:00
1
23:00
7
Source
feed.businesswire.com
2
jaguarhealth.gcs-web.com
1
www.4dpharmaplc.com
1
www.alnylam.com
1
www.biospace.com
32
www.cumulusmedia.com
2
www.empowerclinics.com
2
www.flexlng.com
1
www.globenewswire.com
18
www.lightpath.com
1
www.mmexresources.com
1
www.prnewswire.com
20
www.revgroup.com
1
www.shutterstock.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
publishing date :
2021 - 12 - 13
save search
New Long-Term Results for GIVLAARI® (givosiran) Presented at ASH Annual Meeting & Exposition
Published:
2021-12-13
(Crawled : 00:00)
- alnylam.com
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-17.38%
|
O:
6.02%
H:
2.03%
C:
-0.29%
givlaari
results
Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Published:
2021-12-13
(Crawled : 23:00)
- biospace.com/
TRVN
|
$0.35
-4.37%
-4.57%
170K
|
Health Technology
|
-41.53%
|
O:
6.24%
H:
0.0%
C:
0.0%
trv045
diabetic
diabetes
Teleflex Receives Reimbursement Approval for the UroLift® System in JapanWill expand patient access to breakthrough BPH treatment
Published:
2021-12-13
(Crawled : 23:00)
- biospace.com/
TFX
|
$206.56
-0.4%
0.0%
420K
|
Health Technology
|
-35.37%
|
O:
-0.09%
H:
0.0%
C:
0.0%
urolift
treatment
approval
Technical Communications Corporation Reports Results for the Fiscal Year Ended September 25, 2021
Published:
2021-12-13
(Crawled : 23:00)
- globenewswire.com
TCCO
|
$0.302
59.61%
500
|
Electronic Technology
|
-84.9%
|
O:
14.5%
H:
0.0%
C:
-6.11%
results
communication
communications
92.3 KRST Country to Host Third Annual KRST Country Cares for St. Jude Kids Radiothon Benefiting St. Jude Children’s Research Hospital
Published:
2021-12-13
(Crawled : 23:00)
- cumulusmedia.com
CMLS
|
News
|
$2.98
6.81%
6.38%
61K
|
Consumer Services
|
-77.72%
|
O:
-2.44%
H:
0.0%
C:
0.0%
research
children
iot
CUMULUS MEDIA’s New Country 96.3 and 99.5 The Wolf Raise $630,000 for Cook Children’s in Two-Day Country for the Kids Radiothon
Published:
2021-12-13
(Crawled : 23:00)
- cumulusmedia.com
CMLS
|
News
|
$2.98
6.81%
6.38%
61K
|
Consumer Services
|
-77.72%
|
O:
-2.44%
H:
0.0%
C:
0.0%
media
children
iot
MGM RESORTS INTERNATIONAL ANNOUNCES AGREEMENT TO SELL OPERATIONS OF THE MIRAGE FOR $1.075 BILLION
Published:
2021-12-13
(Crawled : 23:00)
- prnewswire.com
MS
|
News
0 d
|
$90.66
0.44%
0.07%
8.1M
|
Finance
|
-7.35%
|
O:
-1.19%
H:
0.0%
C:
0.0%
MGM
|
$42.42
0.9%
0.0%
2.7M
|
Consumer Services
|
2.36%
|
O:
-2.58%
H:
4.56%
C:
3.07%
New Gold to Sell Blackwater Gold Stream for US$300 Million
Published:
2021-12-13
(Crawled : 23:00)
- prnewswire.com
WPM
|
$52.65
-0.08%
0.0%
1.9M
|
Non-Energy Minerals
|
28.78%
|
O:
-1.71%
H:
1.94%
C:
-0.32%
NGD
|
$1.75
-0.57%
5.4M
|
Non-Energy Minerals
|
22.7%
|
O:
4.26%
H:
0.0%
C:
-7.48%
Fate Therapeutics Showcases Positive Interim Phase 1 Data from FT596 Off-the-shelf, iPSC-derived CAR NK Cell Program for Relapsed / Refractory B-cell Lymphoma at 2021 ASH Annual Meeting
Published:
2021-12-13
(Crawled : 22:00)
- biospace.com/
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-89.06%
|
O:
-0.1%
H:
0.0%
C:
0.0%
ft596
therapeutics
phase 1
positive
t-cell
Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
NOTV
|
$4.31
-8.3%
-9.05%
700K
|
Manufacturing
|
-88.59%
|
O:
-5.14%
H:
5.7%
C:
4.24%
financial results
conference
results
Harpoon Therapeutics Provides Pipeline Update for TriTAC® Clinical Programs and T Cell Engager Platforms
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
HARP
|
$23.01
0.07%
6.6M
|
Health Technology
|
288.34%
|
O:
3.04%
H:
5.74%
C:
3.61%
tritac
therapeutics
platform
t-cell
Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
33.33%
|
O:
1.07%
H:
0.0%
C:
0.0%
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
-87.21%
|
O:
-0.83%
H:
0.0%
C:
0.0%
hoice-01
treatment
trial
lung cancer
positive
therapy
bioscience
results
cancer
phase 3
Notified Announces Fourth Annual Event: A Festival for Communicators, with Keynote by Brendan Hunt of Ted Lasso
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
APO
|
$107.63
0.31%
0.0%
2.2M
|
Finance
|
54.26%
|
O:
-0.3%
H:
0.0%
C:
0.0%
KnowBe4 Releases Top 5 Cybersecurity Tips for the 2021 Holiday Season
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
KNBE
|
$24.89
0.04%
0
|
Information
|
9.12%
|
O:
-0.7%
H:
0.0%
C:
0.0%
cybersecurity
security
Xos Announces Partnership with Merchants Fleet to Grow EV Portfolio for Last Mile Delivery
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
XOS
|
$7.67
-2.29%
-2.35%
33K
|
Manufacturing
|
148.64%
|
O:
-1.51%
H:
0.0%
C:
0.0%
partnership
liver
last mile
CNH Industrial recognized with prestigious double ‘A’ score for global climate and water stewardship by CDP
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
CNHI
|
$12.31
-0.73%
0.0%
6.9M
|
Producer Manufacturing
|
-30.22%
|
O:
-0.48%
H:
0.0%
C:
0.0%
trial
Virco Reports $0.08 Per Share Net Income for Fiscal Third Quarter, 7.6% Increase in Revenue through Nine Months, and Record Backlog
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
VIRC
|
$10.3
-0.48%
-0.49%
66K
|
Producer Manufacturing
|
219.5%
|
O:
-0.31%
H:
0.31%
C:
-1.55%
Tonix Pharmaceuticals Announces Research Collaboration with Columbia University to Study Recombinant Trefoil Factor 2 (rTFF2)-Based Therapy (TNX-1700) for Gastric and Colorectal Cancers
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
TNXP
|
$0.159
1.27%
1.26%
1.1M
|
Health Technology
|
-58.2%
|
O:
0.44%
H:
0.0%
C:
0.0%
tnx-1700
als
research
therapy
collaboration
cancer
colorectal cancer
Aquestive Therapeutics Receives Written Response to Pre-IND Submission for AQST-109 (epinephrine prodrug sublingual film) and Begins Recruitment for its Epinephrine Film Pharmacokinetic and Safety Trial (EPIPHAST)
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
AQST
|
$4.11
-8.67%
-9.49%
2.3M
|
Health Technology
|
-14.45%
|
O:
-3.23%
H:
0.0%
C:
0.0%
aqst-109
drug
trial
therapeutics
epinephrine
submission
Galectin Therapeutics Discusses Corporate Transformation, Progress of NAVIGATE Trial and Outlines Strategy for Potential Phase 2 Cancer Immunotherapy Trial at Annual Meeting
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
GALT
|
$3.37
-0.3%
-0.3%
210K
|
Health Technology
|
50.89%
|
O:
-0.67%
H:
0.0%
C:
0.0%
phase 2
trial
therapeutics
immunotherapy
potential
therapy
cancer
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.